Sleep Science: Feb 8-14

This study used polysomnography to compare swallowing during sleep in head and neck cancer patients versus matched controls. Patients with head and neck cancer showed significantly altered swallowing patterns: more frequent swallowing during sleep, longer swallowing duration while awake, reduced swallowing-related muscle activity during sleep, and more respiratory pauses around swallowing events. These patterns suggest elevated aspiration risk and impaired airway-swallow coordination.

This is one of the first studies to systematically evaluate nocturnal swallowing dysfunction in this population using sleep-lab methods. Because pharyngeal muscles are involved in both swallowing and airway patency, these findings suggest an important overlap between cancer-related swallowing impairment and OSA risk. Earlier sleep evaluation and swallowing-focused rehabilitation may reduce serious respiratory complications.

Researchers developed a patch-type heart rate variability analyzer with AI that achieved 81.4% accuracy for identifying moderate-to-severe OSA (AHI >= 15). The model uses a Cardiovascular Hypopnea Index (CVHI) built from ECG amplitude and nonlinear heart rhythm features and outperformed demographic-only screening (73%) and prior ECG methods (70.6%). The patch is suitable for multi-night home monitoring with less sleep disruption than traditional setups.

Traditional in-lab testing creates access bottlenecks and discomfort that delay diagnosis. A comfortable multi-night patch approach can improve case-finding, enable earlier treatment, and better reflect real-world sleep patterns.

This analysis combined observational data from 790 OSA patients with Mendelian randomization to evaluate causality. Severe OSA was initially associated with clotting abnormalities, but those associations weakened after adjustment for BMI. Genetic analyses did not support a direct causal pathway from OSA to hypercoagulability markers, suggesting obesity is a key driver.

These findings challenge the idea that OSA alone drives thrombotic risk and reinforce the need to pair PAP therapy with aggressive metabolic risk reduction. For overweight patients, weight management may provide cardiovascular and coagulation benefits beyond CPAP alone.

This real-world pathway study screened over 42,000 patients and followed 4,907 longitudinally. Patients progressed rapidly from screening to diagnosis and treatment initiation, with 84.3% adopting PAP, 80.6% meeting 90-day adherence, and 74.2% still adherent at two years. Usage remained strong over time, reaching about 6.4 hours per night and 6 nights per week by year three.

The largest barrier in OSA care is long-term adherence, not device efficacy. These outcomes show that integrated care design, speed, and ongoing behavioral support can transform retention and likely downstream cardiometabolic outcomes.